Market Currents
Cepheid (CPHD +4.8%) gets a boost from a Goldman upgrade to buy, noting the company's new...
-
Friday, September 23, 2011, 2:17 PM ETCepheid (CPHD +4.8%) gets a boost from a Goldman upgrade to buy, noting the company's new product opportunities, increased global TB testing, and improved top-line growth.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
